Pediatric Academic Societies'
Annual Meeting

 Sponsored by the:

 Program   |   Abstracts    |   Exhibits   |   Registration, Housing, Travel  |   International Attendees   |   Presenters   |   CME   |   Press/Media  |   HOME

 

 

Contact Information

Mail Address:

3400 Research Forest Dr., Ste B-7
The Woodlands, TX  77381 USA

Email:  info@pas-meeting.org

Telephone:  281-419-0052

Facsimile:  281-419-0082

 

2006 PAS Annual Meeting

April 29–May 2 
San Francisco, California

Track/Area of Interest


At A Glance Page 
(PDF format)

Return to 
Schedule Home Page

(as of March 24, 2006) 

Epidemiology

Saturday, April 29

8:00am–11:00am
2130—Newborn Hearing Screening: From the Bedside to Beyond
PAS/PIDS Mini Course
Room 3010, Moscone West
Chairs: Mark R. Schleiss and Lisa Ann Schimmenti, University of Minnesota Medical School, Minneapolis, MN

Target Audience: General pediatricians, geneticists and infectious disease specialists.

Sensorineural hearing loss (SNHL) in infants is the most common birth defect, and early detection improves outcome. Evidence from the CDC reveals that less than one half of screened babies are followed up. One possible reason is the low positive predictive value of bedside screening. There is a critical need to augment current strategies to prevent late diagnosis of SNHL. One solution is to propose second-tier testing for the most common causes of SNHL, as the most common causes of newborn hearing loss are infectious and genetic. Of infectious causes, cytomegalovirus (CMV) is the most common. Evidence of CMV infection can be found in 1% of newborns, with 10–15% developing hearing loss or other CNS abnormalities. Of the genetic causes, mutations in GJB2/GJB6 are the most common and are identified in up to one half of individuals with SNHL. The goal of this program will be to examine evidence for inclusion of infectious and genetic screening to augment current newborn screening protocols.

  • Diagnostic Evaluation and Management of Childhood Hearing Loss
    Margaret Alene Kenna, Children's Hospital Boston, Boston, MA

  • Range of Mutations in GJB2-Associated Hearing Loss
    Lisa Ann Schimmenti, University of Minnesota Medical School, Minneapolis, MN

  • Congenital Cytomegalovirus Infection and Hearing Loss
    Karen B. Fowler, University of Alabama at Birmingham, Birmingham, AL

  • Newborn Hearing Screening: Audiologic Assessment
    Yvonne Sininger, University of California Los Angeles, Los Angeles, CA

Sponsored jointly by the Pediatric Infectious Diseases Society and the Pediatric Academic Societies

8:00am–11:00am
2158—The National Survey of Children's Health: Resources and Tips for Using New National and State Data on Child and Adolescent Health
PAS Educational Workshop
Pacific Suite J, SF Marriott
Leader: Christina Bethell, Portland, OR; Co-leaders: Stephen Blumberg, Debra Read

Target Audience: Trainees, fellows, junior faculty, mid-level faculty, senior faculty, and community practitioners.

The National Survey of Children's Health (NSCH) is the largest, nationally representative survey conducted with families to assess the health, well-being and health care of children and youth (n = 102,000). Publicly released in 2005, NSCH provides a wide range of national and state-level data on the health of children, youth and families. Participants will: 1) identify research topics that can be addressed using the NSCH; 2) Obtain hands-on experience using the Data Resource Center—a new resource to easily obtain and download findings from the NSCH; 3) gt ideas on using findings to stimulate efforts to improve care for children, inform research and grant development and advance evidence-based policy, program development, and advocacy.

Objectives:

– Identify the range of research topics that can be addressed using these data.
– Obtain hands-on experience using the Data Resource Center on Child and Adolescent Health (DRC)—a new resource for pediatric clinicians, researchers, and families to easily obtain and download findings from the NSCH (www.childhealthdata.org).
– Get ideas on presenting findings to enhance state and local efforts to improve the health and health care of children, youth, and families.

Format: Presentations, question and answer, hands-on practice using an online data resource center, case examples, real time technical assistance and problem solving.

9:45am–11:45am
2200A—Clinical Trials and Observational Studies
ASPN Workshop
Room 2007, Moscone West
Chairs: Susan L. Furth, Johns Hopkins University, Baltimore, MD; and Craig Wong, Children's Hospital of New Mexico, Albuquerque, NM

Target Audience: Clinical investigators and pediatric nephrologists.

This workshop will address statistical, measurement, ethical and regulatory issues in clinical research. We will discuss methodological issues in randomized clinical trials when the sample size is limited, as often occurs in pediatric studies. We will also address the measurement of kidney function in large cohort studies. Finally, we will have an extended discussion on the evolution of the current regulatory system of clinical research in the United States. This has evolved from concerns about ethical issues and protection of subjects to concerns about protection of the institution through compliance with inflexible requirements. The session will end with suggestions on what changes are needed and how to achieve them in the current regulatory environment.

  • Introduction
    Catherine Stehman-Breen, Amgen, Thousand Oaks, CA

  • Methodologic Issues in Clinical Trials When Sample Size Is Limited
    Tom Greene, The Cleveland Clinic, Cleveland, OH

  • Measurement of Glomerular Filtration Rate in Large Cohort Studies: Design, Conduct and Analysis
    Alvaro Munoz, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD

  • The Dysregulation of Research
    Norman Fost, University of Wisconsin Medical School, Madison, WI

Supported by an unrestricted educational grant from the Kidney and Urology Foundation of America, Inc. (KUFA)

11:45am–2:45pm
2412—Mobilizing High-Risk Communities To Prevent Injuries to Youth
PAS Educational Workshop
Willow, SF Marriott
Leader: Michael Gittelman, Cincinnati, OH; Co-leaders: Wendy Pomerantz, Andrea Gielen, and Mahseeyahu Selassie

Target Audience: Trainees, fellows, junior faculty, mid-level faculty and community practitioners.

The purpose of this workshop is to expand the participants' skills in advocating for high-risk, underserved communities through local involvement. The first portion of this workshop will concentrate on how to obtain and utilize data to identify high-risk communities and their needs. How to prevent injuries will be the example given; yet this model could work for any community intervention. The second portion of the workshop will be interactive with breakouts into small groups. Skill building groups will address: 1) the use of focus groups for strategic thinking/planning; 2) obtaining community buy-in; 3) and identifying and enhancing existing resources to approach a common goal. Areas of success and pitfalls in local efforts will be shared.

Objectives:

– Assessing a communities needs
– Community mobilization/interaction
– Obtaining funding support for community programs

Format: Roundtable discussion, question-and-answer session, problem solving skills.

2:15pm–5:15pm
2705—Vitamin D: More Than Just Calcium and Bone
PAS/LWPES Mini Course
Room 3007-3009, Moscone West
Chairs: Catherine M. Gordon, Children's Hospital of Boston, Boston, MA; and Linda A. DiMeglio, Indiana University, Indianapolis, IN

Target Audience: General pediatricians, gastroenterologists, endocrinologists and hematologists/oncologists.

The understanding of the role of vitamin D in health and illness is becoming more complex. Both skeletal and extra-skeletal actions have been described, and vitamin D analogs are being explored for their anti-proliferative effects. The attendee will gain both clinically relevant epidemiological knowledge as well as review the calcemic and non-calcemic actions of Vitamin D.

  • What Is the Evidence for Vitamin D Deficiency in Children?
    Frank R. Greer, University of Wisconsin, Madison, WI

  • Vitamin D and Extra-Skeletal Actions in Health
    Michael F. Holick, Boston University School of Medicine, Boston, MA

  • Non-calcemic Actions of Vitamin D Receptor Ligands
    Sunil Nagpal, Women's Health & Musculoskeletal Biology, Collegeville PA

Sponsored jointly by the Lawson Wilkins Pediatric Endocrine Society and the Pediatric Academic Societies

3:15pm–5:15pm
2725—Integrating Genetic Susceptibility and Environmental Influences in Pediatric Research
PAS Topic Symposium
Room 2008, Moscone West
Chair: Bruce P. Lanphear, Cincinnati Children's Environmental Health Center, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Target Audience: A broad pediatric audience with the goal of promoting interdisciplinary understanding and greater integration of genetic and environmental research.

Asthma, preterm birth, ADHD and other prevalent pediatric conditions are widely recognized to result from interactions of environmental influences and genetic susceptibility. Tremendous progress has been made in measuring both environmental and genetic risk factors. Increasingly, researchers are moving beyond ecological methods (e.g., questionnaires, air monitoring) to directly measure in humans hundreds of environmental chemicals, from nicotine to metals to DDT and phthalates. Similarly, unprecedented innovation has led rapidly to high-throughput methods that assess DNA variation across large cohorts. New interdisciplinary collaborations that integrate state of the art approaches to both environmental and genetic influences should greatly improve our ability to predict and prevent disease and disability. Such studies will be critical for understanding mechanistic pathways, defining susceptible subpopulations and developing effective interventions. This session will provide an overview of gene–environment research, describe recent advances in biomarkers of environmental exposure and review new methods for measuring genetic variability.

  • Gene–Environment Interaction in Common Pediatric Conditions: Conceptual Overview and Recent Evidence
    Robert S. Kahn, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH

  • Advances in Biomarkers of Environmental Exposure in Pediatric Research
    Bruce P. Lanphear, Cincinnati Children's Environmental Health Center, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

  • Measuring Genetic Susceptibility to the Environment: Study Designs and Genotyping Methods
    Robert O. Wright, Harvard Children's Environmental Health Center, Boston Children's Hospital and the Harvard School of Public Health, Boston, MA

3:15pm–5:15pm
2762—How To Evaluate Medical Literature
PAS Educational Workshop
Golden Gate Hall B3, SF Marriott
Leader: William King, Birmingham, AL

Target Audience: Trainees, fellows, junior faculty, and other health care professionals.

How to Evaluate the Medical Literature. All scientific work must be subjected to rigorous critical appraisal. Although peer review precedes most published medical reports, significant methodological flaws survive the peer review process. Thus, the ultimate evaluation and judgment of the quality of published reports remains with the reader. This workshop will introduce the importance of developing critical appraisal skill, discuss important concepts related to manuscript and journal quality, identify six potential problem areas in a study's methodology, review and apply up to four quantifiable evaluation instruments, assign quality scores to a journal article using one of the instruments, discuss the elements of a good review and apply a review quality instrument to rate the participant's review of a journal article.

Objectives:

– Understand the importance of developing critical appraisal skills.
– Understand the following concepts: quality filtering, peer review, publication bias, journal quality indicators, CONSORT, RQI.
– Identify and apply up to 4 evaluation instruments for evaluating journal articles.
– Identify and apply a review quality instrument.

Format: Introductory lecture and discussion, followed by the participant's application of an evaluation instrument, participant quality scoring of a published article and scoring of the critical review provided by the participant (using a review quality instrument).

Designed to meet elements of the core curriculum for pediatric fellowship subspecialty training.

5:15pm–6:00pm
2800—Clinical Pediatric Hypertension
PAS/ASPN/IPHA Poster Symposium
Room 2004, Moscone West
Chairs: Stephen R. Daniels and Deborah P. Jones

Sponsored jointly by the International Pediatric Hypertension Association and the American Society of Pediatric Nephrology


Sunday, April 30

8:00am–10:00am
3135—Environmental Health: Exposures and Outcomes
PAS Platform Session
Room 2002, Moscone West
Chairs: Ellen F. Crain and Bruce P. Lanphear

8:00am–11:00am
3236—Evidence-Based Advocacy: Turning Research into Action
PAS Educational Workshop
Golden Gate Hall C3, SF Marriott
Leader: Dennis Durbin, Philadelphia, PA; Co-leaders: Flaura Winston, Suzanne Hill

Target Audience: junior faculty, mid-level faculty, senior faculty, and community practitioners.

Evidence-based advocacy integrates the often independent, yet complementary, efforts of clinicians, researchers, public health officials, policymakers and the media to apply scientific principals to widespread health promotion and prevention initiatives. Through case-based illustrations, small-group skill building and brainstorming exercises, workshop participants will learn the critical steps involved in translating research results into a variety of complementary advocacy activities to advance children's health and safety. Strategies including public education through the media, social marketing techniques, legislative advocacy and working collaboratively with industry will be reviewed and discussed. At the completion of the workshop, participants will better understand how to plan and conduct successful advocacy activities for the children in their communities and will know how to access relevant resources in support of their work.

Objectives:

– Learn the steps involved in translating research into a variety of advocacy activities.
– Understand the complementary nature of distinct advocacy activities.
– Practice translating research results into messaging.
– Develop a strategic plan for advocacy.

Format: Case-based demonstrations, group discussion, and small break-out group skill-building.

2:00pm–4:00pm
3700—Developing Valid and Relevant Outcome Measures for Pediatric Emergency Medicine
PAS Topic Symposium
Room 2008, Moscone West
Chairs: Evaline A. Alessandrini, The Children's Hospital of Philadelphia, Philadelphia, PA; and Marc H. Gorelick, Children's Hospital of Wisconsin, Milwaukee, WI

Target Audience: Pediatric and general emergency medicine physicians and/or any health care professional or researcher interested in outcomes and quality improvement.

To improve quality, the Institute of Medicine (IOM) proposes that health care be safe, effective, patient-centered, timely, efficient and equitable. Research using important and relevant outcome measures can distinguish differences in quality of care between health practitioners, settings and patient populations, including factors such as race/ethnicity or socioeconomic status. Defining and accurately measuring outcomes are vital to both clinical research and practice. Yet valid and relevant outcome measures that are applicable to all children receiving emergency care have not been developed or agreed upon. Features of important clinical outcomes include credibility, comprehensiveness, sensitivity, accuracy, biologic sensibility and feasibility. This session will review general (as opposed to condition-specific) outcome measures for use in pediatric emergency medicine, focusing on strengths and weaknesses as well as their relationship to the IOM quality domains. Speakers will discuss outcome and process measures such as health-related quality of life; satisfaction, confidence and trust in health care; mortality; admission rates; emergency department recidivism; length of stay; and costs. A discussion and question-and-answer period will end the session.

  • Introduction
    Evaline A. Alessandrini, The Children's Hospital of Philadelphia, Philadelphia, PA

  • Mortality and Admission Rates
    James M. Chamberlain, Children's National Medical Center, Washington, DC

  • Emergency Department Length of Stay, Costs and Satisfaction
    Marc H. Gorelick, Children's Hospital of Wisconsin, Milwaukee, WI

  • Emergency Department Recidivism, Confidence and Trust in Health Care Practitioners
    Evaline A. Alessandrini, The Children's Hospital of Philadelphia, Philadelphia, PA

  • Health-Related Quality of Life
    Martha (Molly) W. Stevens, Children's Hospital of Wisconsin, Milwaukee, WI

  • Discussion

2:00pm–4:00pm
3705—Infections at the Maternal–Placental–Fetal Interface: Immunopathogenesis of Group B Streptococcus, Listeria monocytogenes and Cytomegalovirus
PAS/PIDS Topic Symposium
Room 3022-3024, Moscone West
Chairs: John R. Schreiber, University of Minnesota Medical School and University of Minnesota Children's Hospital/Fairview, Minneapolis, MN; and Robert F. Pass, University of Alabama at Birmingham, Birmingham, AL

Target Audience: Neonatologists, infectious disease specialists, immunologists, developmental biologists and general pediatricians.

Infections in newborns commonly result from acquisition either during the delivery process or transplacentally. The host and pathogen factors that contribute to acquisition of infections at the maternal–placental–fetal interface are poorly understood. This symposium will review the basic science and immunopathogenesis of three diverse pathogens that all share the ability to cause infections at the placental level: cytomegalovirus, group B streptococcus, and Listeria monocytogenes.

  • Intrauterine Cytomegalovirus Infection, Transplacental Spread of Virus and Control by Maternal Immunity
    Lenore Pereira, University of California San Francisco, San Francisco, CA

  • Host and Bacterial Factors in Invasive Group B Streptococcal Infection
    Craig E. Rubens, University of Washington, Seattle, WA

  • Listeriosis in the Pregnant Guinea Pig: A Model of Vertical Transmission
    Daniel A. Portnoy, University of California Berkeley, Berkeley, CA

  • Discussion

Sponsored jointly by the Pediatric Infectious Diseases Society and the Pediatric Academic Societies

2:00pm–4:00pm
3716—Epidemiology I
PAS Platform Session
Room 2011, Moscone West
Chairs: Diane L. Langkamp and Marshalyn Yeargin-Allsopp

2:00pm–5:00pm
3740—AAP Presidential Plenary and First Annual Silverman Lecture
AAP Presidential Plenary
Room 3007-3011, Moscone West
Chair: Errol R. Alden, American Academy of Pediatrics, Elk Grove Village, IL

Target Audience: Scientists and clinicians interested in the translation of research and evidence-based principles into health policy and practice.

  • AAP Presidential Address
    Eileen M. Ouellette, President, American Academy of Pediatrics, Elk Grove Village, IL

  • The Community Pediatrics Training Initiative: Quality Resident Education in Community Pediatrics
    Jeffrey M. Kaczorowski, University of Rochester, Strong Memorial Hospital, Rochester, NY

  • The Scientific Underpinnings of Preventive Services for Children: The Bright Futures Project
    Paula M. Duncan, University of Vermont, Burlington, VT

  • The Evidence Base Underlying Pay-for-Performance Initiatives
    Paul V. Miles, The American Board of Pediatrics, Chapel Hill, NC

  • Introduction
    Gerald B. Merenstein, University of Colorado School of Medicine, Aurora, CO

  • First Annual William A. Silverman MD Lecture:
    From Disasters to Triumphs—Lessons Learned in the Evolution of Neonatology as a Subspecialty
    Avroy A. Fanaroff, Case Western Reserve University School of Medicine, Cleveland, OH

The Silverman Lecture is sponsored by the AAP Section on Perinatal Pediatrics

2:00pm–5:00pm
3750—Endocrine Disrupters
PAS/LWPES Mini Course
Room 3010-3012, Moscone West
Chairs: Mary M. Lee, University of Massachusetts Medical School, Worcester, MA; and Henry Anhalt, Saint Barnabas Medical Center, Livingston, NJ

Target Audience: Endocrinologists, generalists, neonatologists and basic scientists.

Concerns regarding clinical consequences of endocrine disrupting chemicals have increased over the past decade as researchers have documented detrimental effects in wildlife. Federal attention to endocrine disrupters began in earnest in 1996 when the U.S. Congress passed the Food Quality Protection Act and amended the Safe Drinking Water Act. These laws mandated testing to determine if pesticides and industrial chemicals might behave like hormones; therefore, the U.S. EPA formed the Endocrine Disrupters Screening and Advisory Committee. In addition to direct effects, some environmental disrupters act through non-genomic actions, some of which persist for several generations. This program presenting innovative studies on mechanisms of action of endocrine disruptors will be of critical interest to endocrinologists, both clinical and basic scientists, as well as public health experts.

  • Prenatal Programming with Estrogen/Estrogen Mimetics
    Kenneth S. Korach, National Institute of Environmental Health Sciences, Research Triangle Park, NC

  • Epigenetic Transgenerational Actions of Endocrine Disruptors on Male Fertility and Other Diseases
    Michael K. Skinner, Washington State University, Pullman, WA

  • Prenatal Programming with Native and Environmental Steroids
    Vasantha Padmanabhan, University of Michigan, Ann Arbor, MI

Sponsored jointly by the Lawson Wilkins Pediatric Endocrine Society and the Pediatric Academic Societies

4:15pm–5:45pm
3805—Fetal Homeland Security: New Insights into Old Threats
PAS State of the Art Plenary
Room 3002-3008, Moscone West
Chairs: Phil W. Shaul, University of Texas Southwestern Medical Center, Dallas, TX; and Rashmin C. Savani, University of Texas Southwestern Medical Center, Dallas, TX

Target Audience: Neonatologists, pediatricians and researchers interested in perinatal biology.

In addition to premature birth, there are a select number of maternal conditions that have marked negative impact on the well being of the fetus and newborn. This symposium will highlight recent advances in our understanding of these classical threats to our most vulnerable pediatric patient population.

First, new knowledge of the mechanisms by which maternal diabetes alters embryonic and fetal development will be discussed. Second, the newly discovered role of circulating anti-angiogenic proteins of placental origin in the pathogenesis of preeclampsia will be presented. Finally, novel mechanisms by which biochemical events in the fetal lung trigger the initiation of labor will be discussed. Further advances in each of these realms will ultimately lead to new therapies to protect the fetus and yield healthy outcomes at term.

  • Mechanisms by Which Maternal Diabetes Modifies Embryonic and Fetal Development
    Kelle H. Moley, Washington University School of Medicine, St. Louis, MO

  • Role of Circulating Anti-angiogenic Proteins of Placental Origin in the Pathogenesis of Preeclampsia
    S. Ananth Karumanchi, Harvard Medical School, Beth Isreal Deaconess Medical Center, Boston, MA

  • Fetal–Maternal Signaling in the Initiation of Labor
    Carole R. Mendelson, University of Texas Southwestern Medical Center, Dallas, TX

4:15pm–6:15pm
3850—Human Milk and Breastfeeding
PAS Poster Symposium
Room 3001, Moscone West
Chairs: Sheela R. Geraghty and Ardythe L. Morrow

4:15pm–6:15pm
3870—Neonatal Public Health
PAS Poster Symposium
Room 3014, Moscone West
Chairs: Henrietta S. Bada and Robert A. Sinkin

Includes:

  • Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
    Marie C. McCormick, Harvard School of Public Health and Harvard Medical School, Boston, MA


Monday, May 1

9:00am–12:00pm
4223—Design and Conduct of Randomized Clinical Trials
PAS Educational Workshop
Room Pacific Suite B, SF Marriott
Leader: Mark Klebanoff, Bethesda, MD

Target Audience: Fellows, junior faculty, mid-level faculty, and senior faculty.

It is now almost universally required that randomized trials show new treatments to be superior to current therapy (or no therapy) before the new treatments are adopted. In this workshop we will go through the design and conduct of several clinical trials, from defining the question to conducting the final analysis. The format is didactic with extensive discussion, and we will base as much of the workshop as possible on real-world trials provided by the participants themselves.

Objectives:

– To understand the principles of trial design, conduct and analysis.
– To improve skills in reading publications of clinical trial results.

Format: Didactic sessions with discussion. Real-world examples will be provided by the participants themselves.

Designed to meet elements of the core curriculum for pediatric fellowship subspecialty training.

10:15am–12:15pm
4360—New Perspectives on ADHD
PAS Poster Symposium
Room 2002, Moscone West
Chairs: Marc A. Lerner and Mark L. Wolraich

12:00pm–6:45pm
Commercial Exhibits Open and Posters Available for Viewing
PAS Exhibits
Levels 1 and 2, Moscone West

Posters Available for Viewing: 12:00pm–6:45pm
Author Attendance: 5:15pm–6:45pm

Level 1:
– Critical Care
– Gastroenterology
– Genetics
– Neonatal Epidemiology and Follow Up
– Neonatal Pulmonology
– Neonatology
– Nephrology
– Pulmonology

Level 2:
– Developmental–Behavioral Pediatrics
– Emergency Medicine
– General Pediatrics
– Medical Education

12:15pm–1:15pm
4470—The National Children's Study: Status and Future Plans
PAS/PPC Special Symposium
Room 3010-3012, Moscone West
Chair: Elena Fuentes-Afflick, University of California, San Francisco, CA

Target Audience: Practicing pediatricians, academic child health professionals, researchers, administrators and policymakers who are interested in child health across the lifespan. Professionals interested in the impact of environmental factors on health outcomes will also be interested.

This special symposium will present an update on the National Children's Study, which recently selected 7 vanguard centers and is prepared to begin recruitment of subjects. However, the President's budget proposal allocated no further funding and stated that the study would be terminated at the end of the current fiscal year. The panel presenters will discuss the current budgetary outlook, status of the study, options to implement the study and respond to questions from the audience.

Panelists:

  • Elena Fuentes-Afflick, University of California, San Francisco, CA

  • Duane Alexander, Director, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD

  • Peter C. Scheidt, Director, National Children's Study, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD

  • Alan R. Fleischman, Chair, National Children's Study Federal Advisory Committee, New York Academy of Medicine, New York and National Institutes of Health, Bethesda, MD

  • David J. Schonfeld, Member, National Children's Study Federal Advisory Committee and Chair, AAP Committee on Research, Cincinnati, OH

Sponsored jointly by the Public Policy Council and the Pediatric Academic Societies

5:15pm–6:45pm
Poster Session III
PAS Poster Session
Levels 1 and 2, Moscone West

Posters Available for Viewing: 12:00pm–6:45pm
Author Attendance: 5:15pm–6:45pm

Level 1:
– Critical Care
– Gastroenterology
– Genetics
– Neonatal Epidemiology and Follow Up
– Neonatal Pulmonology
– Neonatology
– Nephrology
– Pulmonology

Level 2:
– Developmental–Behavioral Pediatrics
– Emergency Medicine
– General Pediatrics
– Medical Education


Tuesday, May 2

8:00am–10:00am
5100—Ethical Issues in Housing Health Hazard Research Involving Children
PAS Topic Symposium
Room 2003-2005, Moscone West
Chair: Bernard Lo, University of California San Francisco, San Francisco, CA

Target Audience: A broad pediatric audience with the goal of promoting understanding of ethical issues in conducting community-based research, especially housing hazard research.

Children’s homes may contain hazards that can cause lead toxicity, trigger asthma or result in serious injuries or poisoning. A 2001 court decision, in Grimes versus Kennedy Krieger Institute, highlighted ethical issues in housing-related research and led to substantial controversy and confusion. Many ethical dilemmas occur because research participants are often poor, members of a minority group and have few affordable housing options. Moreover, carrying out research in the home raises unique ethical issues. A forthcoming report from National Academies of Science (NAS) will offer recommendations for conducting research on this topic. This panel will present these NAS recommendations and discuss how they might be applied to specific projects in housing research involving children. Specific issues to be discussed include innovations in research design and informed consent, responding to risks observed in the home, the role of researchers and IRBs and community involvement in research. Audience participation will be encouraged.

  • Recommendations from the National Academies of Science
    Bernard Lo, University of California San Francisco, San Francisco, CA

  • Protecting Vulnerable Research Participants While Allowing Valuable Research To Be Carried Out
    Alan R. Fleischman, Chair, National Children's Study Federal Advisory Committee, New York Academy of Medicine, New York and National Institutes of Health, Bethesda, MD

  • Innovations in Study Design and Informed Consent in Housing Hazard Research Involving Children
    Bruce P. Lanphear, Cincinnati Children's Environmental Health Center, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

  • Resolving Ethical Dilemmas in Housing Hazard Research Through Community Participation
    Brenda Eskenazi, University of California Berkeley, Berkeley CA

  • Discussion

8:00am–10:00am
5105—Not All Near-Term Infants Are Born Equal
PAS Topic Symposium
Room 3002-3008, Moscone West
Chairs: Lucky Jain, Emory University, Atlanta, GA; and Tonse N.K. Raju, National Institute of Child Health and Human Development, Rockville, MD

Target Audience: Neonatologists and pediatricians.

Infants born at >34 weeks and <38 weeks are often presumed to be mature and treated at par with term infants. However, there is considerable epidemiologic information to show that these infants have considerably higher rates of NICU admissions and are at risk for serious morbidity and death. Causes of morbidity include delayed respiratory transition and surfactant deficiency, hyperbilirubinemia, hypothermia, hypoglycemia and poor initiation of feeding, etc. This symposium is designed to review the physiological events related to neonatal transition at birth and the pitfalls in the transition of a near-term infant. The symposium should create awareness among neonatologists and pediatricians for these morbidities and suggest ways to overcome them.

  • Overview
    Lucky Jain, Emory University, Atlanta, GA

  • Epidemiology and Overview of Near-Term Births
    Tonse N.K. Raju, National Institute of Child Health and Human Development, Rockville, MD

  • Respiratory Transition and Morbidity in Near-Term Infants
    Lucky Jain, Emory University, Atlanta, GA

  • Brain Maturation and Pathology in Near-Term Infants
    Hannah Kinney, Harvard University, Boston, MA

  • Hyperbilirubinemia and Kernicterus in Near-Term Infants
    Vinod K. Bhutani, Stanford University School of Medicine, Stanford, CA

  • Post-Discharge Morbidity and Rehospitalization in Near-Term Infants
    Gabriel J. Escobar, Kaiser Permanente, Oakland, CA

  • Discussion

Supported by an unrestricted educational grant from INO Therapeutics

8:00am–10:00am
5160—Epidemiology II
PAS Platform Session
Room 2002, Moscone West
Chairs: José F. Cordero and Jennifer S. Read

8:45am–11:45am
5216—How To Change the World in an Hour a Month: Skills for Effective and Efficient Leadership in Community Health and Child Advocacy
PAS Educational Workshop
Yerba Buena Gardens Salon 4, SF Marriott
Leader: Andy Aligne, Rochester, NY; Co-leaders: Laura Jean Shipley, Jeffrey Kaczorowski, Danielle Thomas-Taylor

Target Audience: Trainees, fellows, junior faculty, mid-level faculty, senior faculty, and community practitioners.

This workshop will enable attendees to leverage their time more effectively when working outside the clinical setting to improve child health at the community level. Facilitated group exercises will improve skills in some or all of the following: time management, teamwork, coping with change, getting involved with community-based organizations, cultural observation, speaking to the media, project planning and evidence-based community health.

Objectives:

– Time management
– Speaking to the media
– Project planning
– Evidence-based community health

Format: Group exercises and group problem solving.

10:00am–2:00pm
Commercial Exhibits Open and Posters Available for Viewing
PAS Exhibits
Levels 1 and 2, Moscone West

Posters Available for Viewing: 10:00am–2:00pm
Author Attendance: 12:00pm–1:30pm

Level 1:
– Adolescent Medicine
– Emergency Medicine
– Epidemiology
– General Pediatrics
– Infectious Diseases
– Neonatal Epidemiology and Follow Up

Level 2:
– Neonatal Pulmonology
– Neonatology

10:15am–11:45am
5405—Newborn Screening: The Coming Revolution
PAS State of the Art Plenary
Room 3001, Moscone West
Chair: Alex R. Kemper, University of Michigan, Ann Arbor, MI

Target Audience: General pediatricians, subspecialists involved with newborn screening, for including neonatologists, endocrinologists, hematologists and geneticists.

Newborn screening has resulted in dramatic improvements in the morbidity and mortality of inherited disorders. Recent laboratory developments have dramatically increased the number of conditions that can be detected in early infancy. Expanding the list of conditions has lead to unique challenges for pediatric practices and public health systems. This symposium will explore these new and emerging challenges.

  • Overview
    Alex R. Kemper, University of Michigan, Ann Arbor, MI

  • New Technologies for Newborn Screening
    Edward R.B. McCabe, David Geffen School of Medicine at UCLA, Mattel Children's Hospital, Los Angeles, CA

  • Meeting the Needs for Confirmation, Counseling and Treatment
    R. Rodney Howell, Miller School of Medicine at the University of Miami, Miami, FL

  • "Treatment" Versus "Benefit" in Evaluating the Desirability of Expanded Newborn Screening
    Don Bailey, University of North Carolina at Chapel Hill, Chapel Hill, NC

  • Ethical Issues That Must Be Addressed in an Expanded Newborn Screening Program
    Ellen Wright Clayton, Vanderbilt University, Nashville, TN

  • Summary Comments
    Michele Puryear, Maternal and Child Health Bureau, Health Resources & Services Administration, Rockville, MD

  • Discussion

10:15am–12:15pm
5425—A Spectrum of Neurodevelopmental Disabilities
PAS Poster Symposium
Room 2006, Moscone West
Chairs: Bruce K. Shapiro and Robert G. Voigt

12:00pm–1:30pm
Poster Session IV
PAS Poster Session
Levels 1 and 2, Moscone West

Posters Available for Viewing: 10:00am–2:00pm
Author Attendance: 12:00pm–1:30pm

Level 1:
– Adolescent Medicine
– Emergency Medicine
– Epidemiology
– General Pediatrics
– Infectious Diseases
– Neonatal Epidemiology and Follow Up

Level 2:
– Neonatal Pulmonology
– Neonatology

Includes:

  • SPR Student Research Award: Metal Contamination of Blood Bank Blood
    Allison Blatz, Case Western Reserve University, Rainbow Babies & Children's Hospital, Cleveland, OH

  • SPR House Officer Research Award: Pathogenesis of Measles Virus Infection in Simian Immunodefiency Virus-Infected, Measles Virus-Vaccinated Rhesus Monkeys
    Sallie R Permar, Children's Hospital and Boston Medical Center, Boston, MA

 

   
 

Copyright: All information contained in this Website is the property of the Pediatric Academic Societies unless otherwise noted. Duplication of any information contained herein for reasons other than personal use requires the expressed written permission of PAS. For comments or concerns about the website, please contact webmaster@pas-meeting.org.

Last Updated: September 26, 2006